Risankizumab
Product Specifications
CAS Number
1612838-76-2
Target
Interleukin|||IL Receptor
Related Pathways
Immunology/Inflammation
Purity
0.983
Bioactivity
Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM) targeting the IL-23 p19 subunit. It inhibits IL-17 production induced by human IL-23 in mouse splenocytes with an IC50 value of 2 pM. Risankizumab is used for the prevention and treatment of immune and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
248419-ML405 100 µL
MALT1 (Mucosa Associated Lymphoid Tissue Lymphoma Translocation Gene 1, DKFZp434L132, MLT, MLT1) (MaxLight 405) discontinued
Ask
View Details 